 |
|
Tissue-Type Plasminogen Activator Should Not Be Used in Acute Ischemic Stroke
Jack E. Riggs, MD
Arch Fam Med. 1997;6(2):102-104.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
FREE FULL TEXT
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
FREE FULL TEXT
3. McNeil BJ, Weichselbaum R, Pauker SG. Fallacy of the five-year survival in lung cancer. N Engl J Med. 1978;299:1397-1401.
ABSTRACT
4. McNeil BJ, Pauker SG, Sox HC, Tversky A. On the elicitation of preferences for alternative therapies. N Engl J Med. 1982;306:1259-1262.
ABSTRACT
5. Tversky A, Kahneman D. The framing of decisions and the psychology of chcice. Science. 1981;211:453-458.
FREE FULL TEXT
6. del Zoppo GJ. Acute stroke: on the threshold of a therapy? N Engl J Med. 1995;333:1632-1633.
FREE FULL TEXT
|
